Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
The Academy endeavours to reach all levels of the society in creating programs that are accessible to one and all with training for Health Volunteers, Asha, Angavadi, school-teachers and students as part of life-skill development
Subscribe To Our Newsletter & Stay Updated
